ASCO posted on LinkedIn:
“Abstract submissions for GU25 are now open!
Help drive innovation and improve patient care in the field by sharing your high-impact data at the leading global event for GU cancers.
Source: ASCO/LinkedIn
ASCO posted on LinkedIn:
“Abstract submissions for GU25 are now open!
Help drive innovation and improve patient care in the field by sharing your high-impact data at the leading global event for GU cancers.
Source: ASCO/LinkedIn